BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olivares M, Laparra M, Sanz Y. Oral administration of Bifidobacterium longum CECT 7347 modulates jejunal proteome in an in vivo gliadin-induced enteropathy animal model. J Proteomics 2012;77:310-20. [PMID: 23023000 DOI: 10.1016/j.jprot.2012.09.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Ruiz L, Hidalgo C, Blanco-míguez A, Lourenço A, Sánchez B, Margolles A. Tackling probiotic and gut microbiota functionality through proteomics. Journal of Proteomics 2016;147:28-39. [DOI: 10.1016/j.jprot.2016.03.023] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
2 Trasciatti S, Piras F, Bonaretti S, Marini S, Nencioni S, Biasci E, Egan CG, Nannipieri F. Effect of oral cholecalciferol in a murine model of celiac disease: a dose ranging study. The Journal of Steroid Biochemistry and Molecular Biology 2022. [DOI: 10.1016/j.jsbmb.2022.106083] [Reference Citation Analysis]
3 Stoven S, Murray JA, Marietta EV. Latest in vitro and in vivo models of celiac disease. Expert Opin Drug Discov 2013;8:445-57. [PMID: 23293929 DOI: 10.1517/17460441.2013.761203] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
4 Pinto-Sánchez MI, Smecuol EC, Temprano MP, Sugai E, González A, Moreno ML, Huang X, Bercik P, Cabanne A, Vázquez H, Niveloni S, Mazure R, Mauriño E, Verdú EF, Bai JC. Bifidobacterium infantis NLS Super Strain Reduces the Expression of α-Defensin-5, a Marker of Innate Immunity, in the Mucosa of Active Celiac Disease Patients. J Clin Gastroenterol 2017;51:814-7. [PMID: 27636409 DOI: 10.1097/MCG.0000000000000687] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
5 Hu J, Ma L, Zheng W, Nie Y, Yan X. Lactobacillus gasseri LA39 Activates the Oxidative Phosphorylation Pathway in Porcine Intestinal Epithelial Cells. Front Microbiol 2018;9:3025. [PMID: 30619122 DOI: 10.3389/fmicb.2018.03025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 McLean MH, Dieguez D, Miller LM, Young HA. Does the microbiota play a role in the pathogenesis of autoimmune diseases? Gut. 2015;64:332-341. [PMID: 25416067 DOI: 10.1136/gutjnl-2014-308514] [Cited by in Crossref: 119] [Cited by in F6Publishing: 117] [Article Influence: 14.9] [Reference Citation Analysis]
7 Chander AM, Yadav H, Jain S, Bhadada SK, Dhawan DK. Cross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunity. Front Microbiol. 2018;9:2597. [PMID: 30443241 DOI: 10.3389/fmicb.2018.02597] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
8 Torun A, Hupalowska A, Trzonkowski P, Kierkus J, Pyrzynska B. Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children. Front Immunol 2021;12:642166. [PMID: 34163468 DOI: 10.3389/fimmu.2021.642166] [Reference Citation Analysis]
9 Laparra JM, Alfonso-García A, Alegría A, Barberá R, Cilla A. 7keto-stigmasterol and 7keto-cholesterol induce differential proteome changes to intestinal epitelial (Caco-2) cells. Food Chem Toxicol 2015;84:29-36. [PMID: 26140950 DOI: 10.1016/j.fct.2015.06.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
10 Ju JM, Marietta EV, Murray JA. Generating Transgenic Mouse Models for Studying Celiac Disease. Methods Mol Biol 2015;1326:23-33. [PMID: 26498609 DOI: 10.1007/978-1-4939-2839-2_3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
11 Ribeiro M, de Sousa T, Sabença C, Poeta P, Bagulho AS, Igrejas G. Advances in quantification and analysis of the celiac-related immunogenic potential of gluten. Compr Rev Food Sci Food Saf 2021;20:4278-98. [PMID: 34402581 DOI: 10.1111/1541-4337.12828] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body. Front Immunol 2021;12:578386. [PMID: 33717063 DOI: 10.3389/fimmu.2021.578386] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
13 Fornai M, Pellegrini C, Benvenuti L, Tirotta E, Gentile D, Natale G, Ryskalin L, Colucci R, Piccoli E, Ghelardi E, Blandizzi C, Antonioli L. Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy. Nutrition 2020;70:110583. [PMID: 31739175 DOI: 10.1016/j.nut.2019.110583] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
14 Francavilla R, Cristofori F, Vacca M, Barone M, De Angelis M. Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease. Expert Rev Gastroenterol Hepatol 2020;14:323-33. [PMID: 32216476 DOI: 10.1080/17474124.2020.1745630] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
15 Chibbar R, Dieleman LA. The Gut Microbiota in Celiac Disease and probiotics. Nutrients 2019;11:E2375. [PMID: 31590358 DOI: 10.3390/nu11102375] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 8.3] [Reference Citation Analysis]
16 Marietta E, Mangalam AK, Taneja V, Murray JA. Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases. Front Immunol 2020;11:573079. [PMID: 33193357 DOI: 10.3389/fimmu.2020.573079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]